Description
General Description
C4-Dpl is normal human serum in which C4 has been removed by immunoaffinity chromatography. The product is tested for the absence of C4 by functional assays for classical and alternative pathway activity and for C4 protein by double immunodiffusion. C4-Dpl is certified to possess a functional alternative pathway for complement activation (Morgan, B.P. (2000); Dodds, A.W. and Sim, R.B. (1997)). Similarly, a functional classical pathway can be reconstituted by addition of purified C4 protein (0.40 mg/mL) indicating that all other complement components necessary for classical and alternative pathway activation are present. The absence of C4 also prevents complement activation by the lectin pathway, but the function of this pathway is not tested. Note that this C4-Dpl serum does not contain C4-derived antigens because it has been depleted by immunoaffinity adsorption of C4.
Specifications
Sizes Available: 1.0 mL/vial
Concentration: >50 mg protein/mL (see Certificate of Analysis for actual conc.)
Form: Frozen liquid
Activity: > 80% versus NHS standard when reconstituted with C4
Purity: No C4 detectable by immunodiffusion
Buffer: 10 mM sodium phosphate, 145 mM NaCl, pH 7.4
Preservative: None, 0.22 µm filtered
Storage: -70o C or below. Minimize freeze/thaw cycles
Source: Normal human serum (shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II).
Precautions: Use normal precautions for handling human blood products.
Origin: Manufactured in the USA.
Safety and Handling
Precautions/Toxicity/Hazards
The source is human serum, therefore precautions appropriate for handling any blood-derived product must be used even though the source was shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II.
Hazard Code: B WGK Germany 3
MSDS is available upon request.